Rentokil Initial PLC
RTO
19.85
-0.10
-0.50%
Rentokil Initial PLC
US · RTO
#1459 by market cap
Listed 1970
19.85
-0.10
-0.50%
Live - 5344 symbols - heartbeat 535s ago
· 2026-10-08 07:00
Pre-market
19.87
+0.10%
After-hours
19.85
0.00%
- Market cap
- 10.03B
- P/E (TTM)i
- 21.05
- P/Bi
- 1.81
- EPSi
- 0.93
- Div yieldi
- 3.12%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on RTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.97, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.40% YoY
Margins
- Gross margin
- 83.12%
- Operating margin
- 9.53%
- Net margin
- 6.80%
Key ratios & quality
- Enterprise valuei
- 13.45B
- PEG ratioi
- 1.12
- Altman Z-Scorei
- 1.97
PEG uses trailing P/E against the 3-year net income growth rate (18.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.14B | 3.56B | 3.82B | 3.99B | 4.49B | 6.39B | 6.62B | 6.91B |
| Gross profit | 2.49B | 2.82B | 3.03B | 3.20B | 3.64B | 5.30B | 5.53B | 5.74B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 349.46M | 377.48M | 411.57M | 496.67M | 412.68M | 776.00M | 715.00M | 658.00M |
| Pretax profit | -144.78M | 443.83M | 313.45M | 438.63M | 358.22M | 566.00M | 462.00M | 390.00M |
| Tax | -20.05M | 71.72M | 59.96M | 83.68M | 77.45M | 129.00M | 116.00M | 100.00M |
| Net profit | -124.73M | 372.11M | 253.49M | 354.95M | 280.77M | 474.00M | 392.00M | 470.00M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | -0.34 | 1.00 | 0.68 | 0.95 | 0.70 | 0.94 | 0.78 | 0.93 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 940.89M | 2.34B | 3.87B | 1.81B | 3.92B | 3.44B | 2.61B | 3.86B |
| Cash & ST investments | 110.90M | 1.54B | 2.88B | 894.81M | 2.61B | 1.99B | 1.16B | 2.32B |
| Inventory | 130.95M | 139.64M | 178.94M | 183.55M | 242.04M | 264.00M | 287.00M | 308.00M |
| Total assets | 3.91B | 5.58B | 7.61B | 5.84B | 14.45B | 14.17B | 13.21B | 14.43B |
| Total current liabilities | 1.58B | 2.33B | 3.68B | 1.88B | 3.44B | 3.28B | 3.22B | 3.32B |
| Short-term debt | 661.73M | 1.33B | 2.27B | 724.76M | 1.79B | 1.61B | 1.62B | 1.58B |
| Long-term debt | 909.55M | 1.39B | 1.82B | 1.70B | 4.33B | 4.02B | 3.13B | 4.16B |
| Total liabilities | 2,853,644,300.07 | 4,263,518,120.31 | 6,067,977,704.19 | 4,129,889,059.84 | 9,492,805,363.60 | 8,965,000,000.00 | 7,918,000,000.00 | 8,940,000,000.00 |
| Total equity | 1.06B | 1.31B | 1.54B | 1.71B | 4.96B | 5.21B | 5.29B | 5.49B |
| Retained earnings | 3.34B | 3.73B | 4.13B | 4.27B | 4.00B | 6.05B | 6.17B | 6.38B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.44B | 3.45B | 2.61B | 3.65B | 3.86B | 4.10B |
| Cash & ST investments | 1.99B | 1.97B | 1.16B | 1.69B | 2.32B | 2.47B |
| Inventory | 264.00M | 258.02M | 287.00M | 281.00M | 308.00M | 314.00M |
| Total assets | 14.17B | 14.21B | 13.21B | 14.23B | 14.43B | 14.56B |
| Total current liabilities | 3.28B | 3.32B | 3.22B | 3.27B | 3.32B | 3.85B |
| Short-term debt | 1.61B | 1.68B | 1.62B | 1.48B | 1.58B | 2.11B |
| Long-term debt | 4.02B | 3.93B | 3.13B | 4.18B | 4.16B | 3.60B |
| Total liabilities | 8,965,000,000.00 | 8,940,858,039.06 | 7,918,000,000.00 | 8,966,000,000.00 | 8,940,000,000.00 | 9,041,000,000.00 |
| Total equity | 5.21B | 5.27B | 5.29B | 5.27B | 5.49B | 5.51B |
| Retained earnings | 6.05B | 4.52B | 6.17B | 6.18B | 6.38B | 6.38B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 461.37M | 606.94M | 746.83M | 759.85M | 726.12M | 916.00M | 868.00M | 972.00M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 245.53M | 382.86M | 538.32M | 543.90M | 496.18M | 654.00M | 593.00M | 703.00M |
| Dividends paid | -94.15M | -112.50M | -- | -187.60M | -147.64M | -252.00M | -292.00M | -304.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 128.03M | 359.13M | 750.92M | 326.61M | 1.06B | 1.06B | 467.00M | 1.59B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -10.79 | 31.38 | 17.76 | 21.89 | 8.42 | 9.55 | 7.33 | 8.70 |
| ROA %i | -3.08 | 8.89 | 4.08 | 5.15 | 2.77 | 3.39 | 2.81 | 3.40 |
| ROIC %i | -3.22 | 14.36 | 6.21 | 7.40 | 4.37 | 5.58 | 4.81 | 5.73 |
| 5-year avg ROE %i | -- | 52.29 | 40.18 | 33.67 | 13.73 | 17.75 | 12.97 | 11.16 |
| EBIT margin %i | -2.38 | 14.48 | 9.73 | 12.13 | 10.04 | 12.69 | 10.98 | 9.26 |
| FCF / sales %i | 7.83 | 10.76 | 13.87 | 13.64 | 11.04 | 9.79 | 8.52 | 10.18 |
| Current ratioi | 0.60 | 1.01 | 1.05 | 0.97 | 1.14 | 1.05 | 0.81 | 1.16 |
| Quick ratioi | 0.46 | 0.94 | 0.99 | 0.86 | 1.05 | 0.95 | 0.71 | 1.05 |
| Debt / assetsi | 41.07 | 52.19 | 56.31 | 44.68 | 45.04 | 42.52 | 38.94 | 42.47 |
| LT debt / equityi | 89.41 | 120.20 | 130.96 | 110.28 | 95.12 | 84.86 | 66.50 | 82.75 |
| Interest coveragei | -1.07 | 7.21 | 6.12 | 10.68 | 4.84 | 3.61 | 3.11 | 2.56 |
| Revenue CAGR (3Y) %i | 6.38 | 9.99 | 5.43 | 8.35 | 8.09 | 18.68 | 18.36 | 15.40 |
| Net income CAGR (3Y) %i | -- | 21.61 | -34.99 | -- | -8.93 | 23.20 | 3.36 | 18.74 |
| FCF CAGR (3Y) %i | 3.91 | 26.31 | 28.81 | 30.36 | 9.03 | 6.70 | 2.92 | 12.32 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.55 | 9.75 | 7.33 | 6.17 | 8.70 | 8.86 |
| ROA %i | 3.39 | 3.56 | 2.81 | 2.29 | 3.40 | 3.32 |
| ROIC %i | 5.58 | 5.99 | 4.81 | 4.18 | 5.73 | 5.61 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.69 | 12.99 | 10.98 | 9.63 | 9.26 | 9.88 |
| FCF / sales %i | 9.79 | 9.21 | 8.52 | 9.47 | 10.18 | 9.91 |
| Current ratioi | 1.05 | 1.04 | 0.81 | 1.12 | 1.16 | 1.06 |
| Quick ratioi | 0.95 | 0.95 | 0.71 | 0.88 | 1.05 | 0.97 |
| Debt / assetsi | 42.52 | 42.30 | 38.94 | 42.44 | 42.47 | 41.83 |
| LT debt / equityi | 84.86 | 82.11 | 66.50 | 86.66 | 82.75 | 72.15 |
| Interest coveragei | 3.61 | 3.57 | 3.11 | 2.82 | 2.56 | 2.63 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Pest Control is the largest reported line at 82.56% of revenue, across 2 reported segments.
- The next-largest line, Hygiene & Wellbeing, is a distant second at 17.44% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Pest Control82.56%
Hygiene & Wellbeing17.44%
Region
United States (US)60.57%
Other countries22.96%
United Kingdom (UK)7.19%
Australia3.65%
France2.69%
Spain1.59%
India1.35%
Quote time 2026-10-08 07:00:57 · For reference only, not investment advice and not tailored to your situation.